Literature DB >> 48775

Rubella-virus infection in juvenile rheumatoid arthritis.

P L Ogra, Y Chiba, S S Ogra, J L Dzierba, J K Herd.   

Abstract

Antibody activity against mumps, measles, polio, and rubella viruses was determined in patients with juvenile rheumatoid arthritis (J.R.A.), rubella-vaccine associated arthritis, adult rheumatoid arthritis, other chronic systemic disorders (e.g., systemic lupus and dermatomyositis), and in a matched population of normal, non-rheumatoid (control) children. The antibody levels against mumps, measles, and poliovirus were similar in all patients. Rubella-antibody levels in rheumatoid arthritis and other systemic disorders were similar to those observed in controls. The mean rubella-antibody levels in rubella-vaccine arthritis were 4 times higher than in controls. The IgM and IgG rubella-antibody levels in J.R.A. were found to be 4-6 times higher when compared to titres observed in the controls. Highest antibody levels were seen in younger children with J.R.A. Detection of rubella-virus antigen was attempted by immunofluorescence in the sediment smears of synovial fluid of patients with J.R.A., adult rheumatoid arthritis, and other non-rheumatoid joint diseases. Specific staining for rubella virus antigen was observed in the synovial fluid of 33 percent of patients with J.R.A. No antigen was detected in the synovial fluid from other patients. These observations suggest a possible role of rubella-virus infection in J.R.A.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48775     DOI: 10.1016/s0140-6736(75)93136-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Juvenile rheumatoid arthritis-a viral disease.

Authors: 
Journal:  Br Med J       Date:  1976-10-16

Review 2.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Role of membrane phospholipids and glycolipids in the Vero cell surface receptor for rubella virus.

Authors:  P Mastromarino; L Cioè; S Rieti; N Orsi
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

4.  Evaluation of the single radial haemolysis (SRH) technique for rubella antibody measurement.

Authors:  S M Russell; S R Benjamin; M Briggs; M Jenkins; P P Mortimer; S B Payne
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

5.  Preventing the congenital rubella syndrome by vaccinating women at risk.

Authors:  J H Joncas
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

6.  Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis.

Authors:  C A Mims; A Stokes; R Grahame
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

7.  Rubella and juvenile chronic arthritis.

Authors:  M F Smith; G B Haycock; R Grahame
Journal:  Arch Dis Child       Date:  1981-04       Impact factor: 3.791

8.  Rubella virus and rheumatoid arthritis.

Authors:  H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

9.  Adult-onset Still's disease.

Authors:  M Harth; J M Thompson; E D Ralph
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

10.  Adult onset Still's disease and viral infections.

Authors:  J M Wouters; J van der Veen; L B van de Putte; D J de Rooij
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.